Health
Astra’s Covid-19 vaccine woes deepen – Vantage
Denmark’s suspension of AZD1222 following blood clots heaps even more pressure on Astra’s US study.
Astrazeneca’s PR battle with its Covid-19 vaccine is intensifying. AZD1222 had already faced questions about its efficacy, and now safety is under the spotlight with the latest scare coming today from Denmark, which has suspended use of the jab as concerns about blood clots mount.
For countries contending with vaccine hesitancy this will be a blow. Even if AZD1222 is exonerated, reports like these will only make those who already have doubts even more reluctant to get a vaccine. For Astra specifically,…
-
Noosa News23 hours agoNew South Wales Blues left to pick up the pieces after fumbling a chance at State of Origin glory
-
Noosa News17 hours agoHelp to make recycling stick
-
Noosa News15 hours agoFormer Darling Downs Zoo employee sheds new light on horrific lion attack on teacher Joanne Cabban
-
Business17 hours agoAlphabet’s stock looks like a brilliant buy right now